Publications
View AllApixaban with Antiplatelet Therapy after Acute Coronary Syndrome
The addition of apixaban, at a dose of 5 mg twice daily, to antiplatelet therapy in high-risk patients after an acute coronary syndrome increased the number of major bleeding ev...
Affiliated Researchers
Institution Info
- Type
- nonprofit
- Country
- CA
- Publications
- 3
- Citations
- 3,409
External Links
Identifiers
- ROR
- https://ror.org/04nv6s061